EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Anticoagulation with Edoxaban in Patients with Atrial High-Rate Episodes

Paulus Kirchhof, Tobias Toennis, Andreas Goette, A John Camm, Hans Christoph Diener, Nina Becher, Emanuele Bertaglia, Carina Blomstrom Lundqvist, Martin Borlich iD, Axel Brandes, Nuno Cabanelas, Melanie Calvert und 24 weitere

New England Journal of Medicine · 28.09.2023 · 389 (13) · 1167-1179

DOI: 10.1056/nejmoa2303062 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift New England Journal of Medicine, erschienen am 28.09.2023. Verfasst von Paulus Kirchhof und 35 weiteren Autor:innen. Beteiligte Einrichtung: From the Atrial Fibrillation Network, Münster (P.K., A.G., U.S.), the Department of Cardiology, University Heart and Vascular Center Hamburg (P.K., T…. Hauptthemen laut MEDLINE: Anticoagulants, Embolism, Factor Xa Inhibitors, Arrhythmias, Cardiac. Die Arbeit wurde bisher 427-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: British Heart Foundation, Leducq Foundation, BMBF (German Ministry of Education and Research, Berlin, Germany) through the DZHK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnticoagulantsEmbolismFactor Xa InhibitorsArrhythmias, CardiacAgedFemaleHumansMaleAtrial FibrillationHemorrhageStrokeElectrodes, ImplantedDouble-Blind MethodRisk FactorsPyridinesThiazoles

Substanzen

AnticoagulantsFactor Xa InhibitorsedoxabanPyridinesThiazoles

Autor:innen und Institutionen

  • From the Atrial Fibrillation Network, Münster (P.K., A.G., U.S.), the Department of Cardiology, University Heart and Vascular Center Hamburg (P.K., T.T., N.B.), and the Institute of Medical Biometry and Epidemiology (A.…

ORCID-Profile: Martin Borlich

Förderung

  • British Heart Foundation
  • Leducq Foundation
  • BMBF (German Ministry of Education and Research, Berlin, Germany) through the DZHK
  • DZHK (German Center for Cardiovascular Research), Berlin, Germany
  • Daiichi Sankyo Europe
  • European Union, CATCH ME
  • AFFECT-EU
  • MAESTRIA

Zitieren

APA

Kirchhof, P., Toennis, T., Goette, A., Camm, A. J., Diener, H. C., Becher, N., Bertaglia, E., Blomstrom Lundqvist, C., Borlich, M., Brandes, A., Cabanelas, N., Calvert, M., Chlouverakis, G., Dan, G. A., de Groot, J. R., Dichtl, W., Kravchuk, B., Lubiński, A., Marijon, E., …, & NOAH-AFNET6 sites and investigators (2023). Anticoagulation with Edoxaban in Patients with Atrial High-Rate Episodes. New England Journal of Medicine, 389(13), 1167-1179. https://doi.org/10.1056/nejmoa2303062

Vancouver

Kirchhof P, Toennis T, Goette A, Camm AJ, Diener HC, Becher N, et al. Anticoagulation with Edoxaban in Patients with Atrial High-Rate Episodes. New England Journal of Medicine. 2023;389(13):1167-1179. doi:10.1056/nejmoa2303062

BibTeX
@article{Kirchhof2023,
  author = {Kirchhof, Paulus and Toennis, Tobias and Goette, Andreas and Camm, A John and Diener, Hans Christoph and Becher, Nina and Bertaglia, Emanuele and Blomstrom Lundqvist, Carina and Borlich, Martin and Brandes, Axel and Cabanelas, Nuno and Calvert, Melanie and Chlouverakis, Gregory and Dan, Gheorghe-Andrei and de Groot, Joris R and Dichtl, Wolfgang and Kravchuk, Borys and Lubiński, Andrzej and Marijon, Eloi and Merkely, Béla and Mont, Lluís and Ozga, Ann-Kathrin and Rajappan, Kim and Sarkozy, Andrea and Scherr, Daniel and Sznajder, Rafał and Velchev, Vasil and Wichterle, Dan and Sehner, Susanne and Simantirakis, Emmanuel and Lip, Gregory Y H and Vardas, Panos and Schotten, Ulrich and Zapf, Antonia and NOAH-AFNET 6 Investigators, NOAH-AFNET 6 Investigators and NOAH-AFNET6 sites and investigators, NOAH-AFNET6 sites and investigators},
  title = {Anticoagulation with Edoxaban in Patients with Atrial High-Rate Episodes},
  journal = {New England Journal of Medicine},
  year = {2023},
  volume = {389},
  number = {13},
  pages = {1167--1179},
  doi = {10.1056/nejmoa2303062}
}
Kostenlos starten →